Status:
COMPLETED
Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID)
Lead Sponsor:
Poitiers University Hospital
Conditions:
COVID-19
Chilblains
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
Cases of chilblains have been reported with an unusual frequency in France in the context of the COronaVirus Infectious Disease 2019 (COVID-19) epidemic. Some of these cases have been linked to a viro...
Eligibility Criteria
Inclusion
- Patient over the age of majority or a minor over 12 years of age accompanied by his/her legal representative
- Benefiting from a Social Security scheme
- Informed consent signed by the patient (if major) or by his legal representative (if minor) after clear, fair and appropriate information about the study.
- Red and swollen lesions of the hands and/or feet evolving for more than 24 hours in the context of a COVID-19 epidemic.
- PCR SARS-CoV-2 PCR on nasopharyngeal swab with results available, prior to the inclusion visit.
- Absence of fever or respiratory signs suggestive of COVID-19 for at least 14 days
Exclusion
- A person who does not benefit from a Social Security scheme or who does not benefit from it through a third party.
- Patient who is subject to a judicial safeguard measure
- Allergy to local anaesthetic products
- Fever or respiratory signs suggestive of COVID-19 within 14 days
Key Trial Info
Start Date :
April 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04387955
Start Date
April 30 2020
End Date
July 30 2021
Last Update
November 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Poitiers
Poitiers, France, 86000